CenterStar Asset Management’s GSK GSK Stock Holding History

CenterStar Asset Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,700	Closed	-$260K	–	291
2025 Q1	$260K	Buy	+6,700	New	+$245K	0.06%	282
2024 Q1	–	Sell	-8,800	Closed	-$326K	–	312
2023 Q4	$326K	Buy	8,800 +1,200	+16%	+$43.1K	0.05%	238
2023 Q3	$276K	Buy	+7,600	New	+$270K	0.06%	266
2020 Q2	–	Hold	0	–	-$76K	–	789
2020 Q1	–	Hold	0	–	–	–	343
2019 Q4	–	Hold	0	–	–	–	346

Other funds holding GSK

Fidelity Investments

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return